DPP4 and diabetes mellitus: A clinical trial (https://www.clinicaltrials.gov, NCT01102699) demonstrated that participants with DM challenged with G-CSF have a reduced mobilization of HSCs, due to altered expression of dipeptidyl peptidase-4 (DPP4, also known as adenosine deaminase complexing protein 2 or CD26) [78, 79].